17:30 EST Alterity Therapeutics (ATHE) Ltd (ADR) trading halted, news pending
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATHE:
- Alterity Therapeutics downgraded to Hold from Speculative Buy at Benchmark
- Alterity Therapeutics price target raised to $12 from $8 at Maxim
- Alterity Therapeutics announces ATH434 Phase 2 trial results
- Alterity Therapeutics Ltd (ADR) trading halted, news pending
- Alterity Therapeutics reports cash balance of A$4.54M as of December 31
Questions or Comments about the article? Write to editor@tipranks.com